Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W Cross

Showing results (411-420 of 448) with videos related to

Pageof 45
Sort By:
Biorxiv : the Preprint Server for Biology|August 21, 2020
Alpha-1-antitrypsin and its variant-dependent role in COVID-19 pathogenesisChristian S Stevens, Kasopefoluwa Y Oguntuyo, Shreyas Kowdle, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 10, 2021
Therapy for Argentine hemorrhagic fever in nonhuman primates with a humanized monoclonal antibodyLarry Zeitlin, Robert W Cross, Joan B Geisbert, et al.
Nature Medicine|September 5, 2017
Human-monoclonal-antibody therapy protects nonhuman primates against advanced Lassa feverChad E Mire, Robert W Cross, Joan B Geisbert, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 18, 2025
Fracture-related hospitalisations in newly diagnosed high-risk localised or metastatic hormone-sensitive prostate cancer: secondary analysis of the STAMPEDE phase III trials of docetaxel and zoledronic acid using healthcare systems dataC Jones, P Dutey-Magni, L R Murphy, et al.
The Journal of Clinical Investigation|December 11, 2019
Quadrivalent VesiculoVax vaccine protects nonhuman primates from viral-induced hemorrhagic fever and deathRobert W Cross, Rong Xu, Demetrius Matassov, et al.
Journal of Medicinal Chemistry|January 6, 2026
Discovery and Optimization of First-in-Class Furopyrimidine-Based Inhibitors of HenipavirusesIrina N Gaisina, Malaika D Argade, Ryan Bott, et al.
Vaccines|October 27, 2022
Nonhuman Primates Are Protected against Marburg Virus Disease by Vaccination with a Vesicular Stomatitis Virus Vector-Based Vaccine Prepared under Conditions to Allow Advancement to Human Clinical TrialsChristopher L Cooper, Gavin Morrow, Maoli Yuan, et al.
The Journal of Infectious Diseases|July 20, 2023
Long-term Prophylaxis Against Aerosolized Marburg Virus in Nonhuman Primates With an Afucosylated Monoclonal AntibodyDafna Abelson, Jennifer Barajas, Lauren Stuart, et al.
Science Translational Medicine|July 15, 2021
Ebola vaccine-induced protection in nonhuman primates correlates with antibody specificity and Fc-mediated effectsMichelle Meyer, Bronwyn M Gunn, Delphine C Malherbe, et al.
Science (New York, N.Y.)|March 14, 2024
Oral administration of obeldesivir protects nonhuman primates against <i>Sudan ebolavirus</i>Robert W Cross, Courtney Woolsey, Victor C Chu, et al.
Pageof 45

Showing results (411-420 of 448) with videos related to

Sort By:
Pageof 45
Biorxiv : the Preprint Server for Biology|August 21, 2020
Alpha-1-antitrypsin and its variant-dependent role in COVID-19 pathogenesisChristian S Stevens, Kasopefoluwa Y Oguntuyo, Shreyas Kowdle, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 10, 2021
Therapy for Argentine hemorrhagic fever in nonhuman primates with a humanized monoclonal antibodyLarry Zeitlin, Robert W Cross, Joan B Geisbert, et al.
Nature Medicine|September 5, 2017
Human-monoclonal-antibody therapy protects nonhuman primates against advanced Lassa feverChad E Mire, Robert W Cross, Joan B Geisbert, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 18, 2025
Fracture-related hospitalisations in newly diagnosed high-risk localised or metastatic hormone-sensitive prostate cancer: secondary analysis of the STAMPEDE phase III trials of docetaxel and zoledronic acid using healthcare systems dataC Jones, P Dutey-Magni, L R Murphy, et al.
The Journal of Clinical Investigation|December 11, 2019
Quadrivalent VesiculoVax vaccine protects nonhuman primates from viral-induced hemorrhagic fever and deathRobert W Cross, Rong Xu, Demetrius Matassov, et al.
Journal of Medicinal Chemistry|January 6, 2026
Discovery and Optimization of First-in-Class Furopyrimidine-Based Inhibitors of HenipavirusesIrina N Gaisina, Malaika D Argade, Ryan Bott, et al.
Vaccines|October 27, 2022
Nonhuman Primates Are Protected against Marburg Virus Disease by Vaccination with a Vesicular Stomatitis Virus Vector-Based Vaccine Prepared under Conditions to Allow Advancement to Human Clinical TrialsChristopher L Cooper, Gavin Morrow, Maoli Yuan, et al.
The Journal of Infectious Diseases|July 20, 2023
Long-term Prophylaxis Against Aerosolized Marburg Virus in Nonhuman Primates With an Afucosylated Monoclonal AntibodyDafna Abelson, Jennifer Barajas, Lauren Stuart, et al.
Science Translational Medicine|July 15, 2021
Ebola vaccine-induced protection in nonhuman primates correlates with antibody specificity and Fc-mediated effectsMichelle Meyer, Bronwyn M Gunn, Delphine C Malherbe, et al.
Science (New York, N.Y.)|March 14, 2024
Oral administration of obeldesivir protects nonhuman primates against <i>Sudan ebolavirus</i>Robert W Cross, Courtney Woolsey, Victor C Chu, et al.
Pageof 45